Pathways of Progression From Intraductal Papillary Mucinous Neoplasm to Pancreatic Ductal Adenocarcinoma Based on Molecular Features
Yuko Omori(Hokkaido University), Shinya Tanaka(Hokkaido University), Mishie Tanino(Asahikawa Medical University), Yusuke Mizukami(Asahikawa Medical College Hospital), Jin Katayama(Thermo Fisher Scientific (Japan)), Yoshiyasu Ambo(Hokkaido University of Science), Hiroyuki Maguchi(Teine Keijinkai Hospital), Atsuko Sumi(Sapporo Higashi Tokushukai Hospital), Hidenori Karasaki(Sapporo Higashi Tokushukai Hospital), Hiroshi Nishihara(Keio University), Toshikatsu Okumura(Asahikawa Medical University), Junpei Sasajima(Asahikawa Medical College Hospital), Kenzui Taniue(Asahikawa Medical College Hospital), Toshiya Shinohara(Hokkaido University), Jun Ueda(Chubu University), Kuniyuki Takahashi(Teine Keijinkai Hospital), Hiroshi Yamaguchi(Saitama Medical University), Yusuke Ono(Tokyo Metropolitan Institute of Gerontology), Katsuro Enomoto(Asahikawa Medical University), Miho Muraki, Toru Furukawa(Shohoku College)
Cited by 180
Related Papers
Whole-exome sequencing uncovers frequent GNAS mutations in intraductal papillary mucinous neoplasms of the pancreas
|Scientific Reports|2011|434
Induction of interleukin-8 preserves the angiogenic response in HIF-1α–deficient colon cancer cells
|Nature Medicine|2005|407
Randomized clinical trial of adjuvant gemcitabine chemotherapy <i>versus</i> observation in resected bile duct cancer
|British journal of surgery|2018|401
Distal Pancreatectomy With En Bloc Celiac Axis Resection for Locally Advanced Pancreatic Body Cancer
|Annals of Surgery|2007|315
Crk and CrkL adaptor proteins: networks for physiological and pathological signaling
|Cell Communication and Signaling|2009|277